Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
198 |
|
| Actual shortage: | 8 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 26 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2018-03-19 | 2020-06-10 | 43360 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2018-03-23 | 2020-06-10 | 43857 |
| PROPOFOL INJECTION | 10MG | EMULSION | Avoided shortage | 2023-11-17 | 2024-05-03 | 210580 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2023-11-17 | 2024-01-10 | 210583 |
| PROPOFOL INJECTION | 10MG | EMULSION | Avoided shortage | 2023-11-17 | 2024-05-03 | 210586 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2024-04-19 | 2024-05-03 | 225667 |
| OLIMEL 4.4% E | 2.64G 0.74G 1.50G 6.41G 8G 154G 3.67G 0.81G 0.52G 2.24G 32G 2.21G 3.07G 2.21G 0.11G 2.64G 4.34G 2.83G 1.28G 2.21G 3.07G 3.07G 2.21G 3.48G 1.75G | EMULSION | Resolved | 2017-07-10 | 2017-08-16 | 15024 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2019-05-15 | 2019-06-07 | 84202 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2019-07-29 | 2019-08-27 | 90084 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2020-01-17 | 2020-02-12 | 103474 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2020-03-24 | 2020-04-25 | 109301 |
| TISSEEL | 40MCMOL 500UNIT 3000KIU 125MG | KIT | Actual shortage | 2024-05-29 | 2024-05-29 | 229097 |
| TISSEEL | 40MCMOL 500UNIT 3000KIU 125MG | KIT | Actual shortage | 2024-05-29 | 2024-05-29 | 229100 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2017-08-15 | 2018-03-01 | 19378 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2017-10-17 | 2018-11-27 | 26121 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2017-12-08 | 2018-11-27 | 32177 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56915 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56918 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-12-05 | 2019-02-26 | 68703 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2019-02-15 | 2019-04-11 | 76013 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120958 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120961 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |